Moderna, Inc. Website

Moderna, Inc.

NasdaqGS-MRNA

Basic

  • Market Cap

    $47.54B

  • EV

    $36.62B

  • Shares Out

    383.24M

  • Revenue

    $5,153M

  • Employees

    5,600

Margins

  • Gross

    -70.27%

  • EBITDA

    -88.49%

  • Operating

    -99.73%

  • Pre-Tax

    -93.19%

  • Net

    -115.82%

  • FCF

    -71.26%

Returns (5Yr Avg)

  • ROA

    9.07%

  • ROTA

    21.73%

  • ROE

    21.73%

  • ROCE

    23.99%

  • ROIC

    -0.86%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $145.9

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    $8,523M

  • Net Debt

    -$10.92B

  • Debt/Equity

    0.1

  • EBIT/Interest

    -146.83

Growth (CAGR)

  • Rev 3Yr

    23.55%

  • Rev 5Yr

    111.4%

  • Rev 10Yr

  • Dil EPS 3Yr

    118.87%

  • Dil EPS 5Yr

    38.08%

  • Dil EPS 10Yr

  • Rev Fwd 2Yr

    -16.2%

  • EBITDA Fwd 2Yr

    -67.53%

  • EPS Fwd 2Yr

    -72.29%

  • EPS LT Growth Est

    -51.34%

Dividends

  • Yield

  • Payout

  • DPS

  • DPS Growth 3Yr

  • DPS Growth 5Yr

  • DPS Growth 10Yr

  • DPS Growth Fwd 2Yr

Select a metric from the list below to chart it

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

LTM

Dec '24 (E)

Dec '25 (E)

Dec '26 (E)

Operating Revenues

60

803

17,675

18,435

6,671

5,010

Other Revenues, Total

796

828

177

143

Total Revenues

60

803

18,471

19,263

6,848

5,153

Total Revenues % Chg.

-55.6%

1,238.3%

2,200.2%

4.3%

-64.4%

-65.8%

Cost of Goods Sold, Total

496

1,378

4,608

8,711

9,538

8,774

Gross Profit

-436

-575

13,863

10,552

-2,690

-3,621

Selling General & Admin Expenses, Total

110

188

567

1,132

1,549

1,518

Other Operating Expenses, Total

110

188

567

1,132

1,549

1,518

Operating Income

-546

-763

13,296

9,420

-4,239

-5,139

Interest Expense, Total

-10

-17

-29

-38

-35

Interest And Investment Income

39

25

18

200

421

432

Net Interest Expenses

39

15

1

171

383

397

Other Non Operating Income (Expenses)

-8

4

-12

4

-14

-8

EBT, Excl. Unusual Items

-515

-744

13,285

9,595

-3,870

-4,750

Gain (Loss) On Sale Of Investments

-20

-72

-52

Gain (Loss) On Sale Of Assets

Other Unusual Items

EBT, Incl. Unusual Items

-515

-744

13,285

9,575

-3,942

-4,802

Income Tax Expense

-1

3

1,083

1,213

772

1,166

Earnings From Continuing Operations

-514

-747

12,202

8,362

-4,714

-5,968

Net Income

-514

-747

12,202

8,362

-4,714

-5,968

Preferred Dividend and Other Adjustments

Net Income to Common Incl Extra Items

-514

-747

12,202

8,362

-4,714

-5,968

Net Income to Common Excl. Extra Items

-514

-747

12,202

8,362

-4,714

-5,968

Total Shares Outstanding

336.5

398.8

403

385

382

383

Weighted Avg. Shares Outstanding

331

381

403

394

382

381

Weighted Avg. Shares Outstanding Dil

331

381

431

416

382

381

EPS

-1.6

-2

30.3

21.2

-12.3

-15.7

EPS Diluted

-1.6

-2

28.3

20.1

-12.3

-15.7

EBITDA

-515

-732

13,528

9,768

-3,618

-4,560

Effective Tax Rate

0.2%

-0.4%

8.2%

12.7%

-19.6%

-24.3%